Sanjib Basu to Antineoplastic Agents
This is a "connection" page, showing publications Sanjib Basu has written about Antineoplastic Agents.
Connection Strength
0.173
-
Clinical and safety profile of high-dose interleukin-2 treatment in elderly patients with metastatic melanoma and renal cell carcinoma. Oncology. 2013; 84(2):123-6.
Score: 0.088
-
Utility of insulin-like growth factor receptor-1 expression in gefitinib-treated patients with non-small cell lung cancer. Anticancer Res. 2012 May; 32(5):1705-10.
Score: 0.085